WO2013055104A3 - 과민성방광 증후군 예방 및 치료용 조성물 - Google Patents

과민성방광 증후군 예방 및 치료용 조성물 Download PDF

Info

Publication number
WO2013055104A3
WO2013055104A3 PCT/KR2012/008215 KR2012008215W WO2013055104A3 WO 2013055104 A3 WO2013055104 A3 WO 2013055104A3 KR 2012008215 W KR2012008215 W KR 2012008215W WO 2013055104 A3 WO2013055104 A3 WO 2013055104A3
Authority
WO
WIPO (PCT)
Prior art keywords
overactive bladder
composition
bladder syndrome
preventing
treating overactive
Prior art date
Application number
PCT/KR2012/008215
Other languages
English (en)
French (fr)
Other versions
WO2013055104A2 (ko
Inventor
황세희
김민정
이진희
이은주
Original Assignee
씨제이제일제당(주)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 씨제이제일제당(주) filed Critical 씨제이제일제당(주)
Priority to CN201280049812.4A priority Critical patent/CN103930121A/zh
Publication of WO2013055104A2 publication Critical patent/WO2013055104A2/ko
Publication of WO2013055104A3 publication Critical patent/WO2013055104A3/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/42—Cucurbitaceae (Cucumber family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

본 발명은 호박씨오일 또는 호박씨추출물, 대두추출물 및 마그네슘을 주성분으로 포함하는 조성물에 관한 것으로, 보다 상세하게는 골반저 및 하부요로의 근육강화와 배뇨근의 과도한 수축억제를 통해 과민성방광 증후군의 야간뇨, 빈뇨 및 절박뇨를 감소시키는 효과 및 이에 따른 삶의 질 개선에 효과를 주는 과민성방광 증후군의 치료 및 예방을 위한 조성물 및 이를 포함하는 의약품, 건강기능성식품 및 일반식품에 관한 것이다.
PCT/KR2012/008215 2011-10-11 2012-10-10 과민성방광 증후군 예방 및 치료용 조성물 WO2013055104A2 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201280049812.4A CN103930121A (zh) 2011-10-11 2012-10-10 膀胱过度活动症候群预防及治疗用组合物

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020110103613A KR101362539B1 (ko) 2011-10-11 2011-10-11 과민성방광 증후군 예방 및 치료용 조성물
KR10-2011-0103613 2011-10-11

Publications (2)

Publication Number Publication Date
WO2013055104A2 WO2013055104A2 (ko) 2013-04-18
WO2013055104A3 true WO2013055104A3 (ko) 2013-07-04

Family

ID=48082651

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2012/008215 WO2013055104A2 (ko) 2011-10-11 2012-10-10 과민성방광 증후군 예방 및 치료용 조성물

Country Status (3)

Country Link
KR (1) KR101362539B1 (ko)
CN (1) CN103930121A (ko)
WO (1) WO2013055104A2 (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101513799B1 (ko) * 2013-08-12 2015-04-20 충북대학교 산학협력단 생강 추출물의 수용성 분획물을 유효성분으로 포함하는 배뇨근 저활동성의 예방 및 치료용 약학적 조성물
KR101513800B1 (ko) * 2013-08-12 2015-04-20 충북대학교 산학협력단 생강 추출물의 비극성 용매 분획물을 유효성분으로 포함하는 과민성방광의 예방 및 치료용 약학적 조성물
CN105232989A (zh) * 2015-11-13 2016-01-13 济南新时代医药科技有限公司 一种治疗老年女性特发性膀胱过度活动症的中药
ITUB20160585A1 (it) * 2016-02-09 2017-08-09 Naturmed S R L Nutriceutico per il trattamento della urgenza minzionale
CN106860814B (zh) * 2017-01-22 2020-02-18 哈尔滨快好药业有限公司 一种改善女性尿频、尿失禁的保健食品组合物及其制备方法和应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040065506A (ko) * 2003-01-14 2004-07-22 강순아 대두 추출물을 함유하는 아세틸콜린에스터라제 저해제그리고 이를 포함하는 약학적 제제 및 식품
KR100462173B1 (ko) * 2004-06-08 2004-12-16 안국약품 주식회사 요실금 예방 및 치료용 조성물
KR20050087306A (ko) * 2004-02-26 2005-08-31 김천수 전립선 및 방광을 위한 건강식품 제조방법
KR20070046930A (ko) * 2004-08-18 2007-05-03 바이올로직 헬스 솔루션즈 피티와이 리미티드 요실금 및 과민성 방광의 예방 또는 치료용 허브 조성물
KR100815171B1 (ko) * 2000-08-02 2008-03-19 가부시키가이샤 롯데 시클로옥시게나아제 저해제 및 그를 함유하는 음식품

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100815171B1 (ko) * 2000-08-02 2008-03-19 가부시키가이샤 롯데 시클로옥시게나아제 저해제 및 그를 함유하는 음식품
KR20040065506A (ko) * 2003-01-14 2004-07-22 강순아 대두 추출물을 함유하는 아세틸콜린에스터라제 저해제그리고 이를 포함하는 약학적 제제 및 식품
KR20050087306A (ko) * 2004-02-26 2005-08-31 김천수 전립선 및 방광을 위한 건강식품 제조방법
KR100462173B1 (ko) * 2004-06-08 2004-12-16 안국약품 주식회사 요실금 예방 및 치료용 조성물
KR20070046930A (ko) * 2004-08-18 2007-05-03 바이올로직 헬스 솔루션즈 피티와이 리미티드 요실금 및 과민성 방광의 예방 또는 치료용 허브 조성물

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
GABY,A.R.: "Magnesium Treats Urinary Urge Incontinence", BASTYR CENTER WEBSITE, 2003, Retrieved from the Internet <URL:http://bastyrcenter.org/content/view/792> *

Also Published As

Publication number Publication date
KR101362539B1 (ko) 2014-02-14
WO2013055104A2 (ko) 2013-04-18
CN103930121A (zh) 2014-07-16
KR20130039133A (ko) 2013-04-19

Similar Documents

Publication Publication Date Title
WO2013055104A3 (ko) 과민성방광 증후군 예방 및 치료용 조성물
WO2013153071A3 (en) A nutritional composition
MX2010009199A (es) Bebida a base de leche y metodo para evitar sabores desagradables en una bebida a base de leche.
JO2975B1 (en) Formulation to improve sexual health
WO2011010921A3 (en) Compositions for reducing gastro-intestinal methanogenesis in ruminants
NZ589308A (en) Use of angiogenin or angiogenin agonists for treating diseases and disorders
NZ595939A (en) Use of modified peptide gamma-glu-abu for imparting or enhancing food or beverage taste
WO2011090270A3 (ko) 오스모틴을 포함하는 신경질환의 예방 및 치료용 조성물
IN2012DN01984A (ko)
MY153859A (en) Reducing astringency in compositions containing phenolic compounds
MX2009003376A (es) Mezcla de sales de hierro y cobre que enmascaran el sabor metalico.
WO2008007244A3 (en) Composition for improving eye health
MY172673A (en) Non-alcohol, beer-taste beverage having substantiality in taste
WO2013093096A8 (en) Ellagitannins rich extracts composition in sexual wellness
MY161578A (en) Composition for reducing absorption of dietary fat
WO2010147440A3 (ko) 밤껍질 추출물을 포함하는 건강 식품 또는 약학 조성물
MX2011012071A (es) Prevencion y tratamiento de diarrea alergica.
WO2009091120A3 (en) Composition comprising the extracts of lindera obtusiloba for prevention and treatment of cardiovascular diseases
MY174494A (en) Method for inhibiting pathogens using a nutritional composition
WO2012024583A3 (en) Oxysterol compounds
MY175787A (en) An instant oil fried noodle containing iron and its process of preparation
MX2010006081A (es) Una bebida saludable y un metodo para mejorar la estabilidad de una bebida.
WO2011042501A3 (en) Glp-2 for use in intestine and muscle recovery
EP2501371A4 (en) USE OF HYDROXYTYROSOL FOR IMPROVED MUSCLE DIFFERENTIATION
WO2009146490A8 (en) A method for increasing bone density and/or reducing any osteochondral defects in an animal and a composition including vitamin k

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12840581

Country of ref document: EP

Kind code of ref document: A2

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC , EPO FORM 1205A DATED 13.08.2014

122 Ep: pct application non-entry in european phase

Ref document number: 12840581

Country of ref document: EP

Kind code of ref document: A2